SCHEMBL1084334

SCHEMBL1084334

CN(C)c1nc(-c2cc(Cl)ccc2O)nc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 12/20 0.57
CYP1A2 P05177 11/20 0.57
CLK4 Q9HAZ1 7/20 0.57
CYP2C19 P33261 7/20 0.57
TSHR P16473 6/20 0.57
MAPK1 P28482 2/20 0.57
CYP3A4 P08684 9/20 0.53
ALDH1A1 P00352 7/20 0.53
HSD17B10 Q99714 6/20 0.53
ALOX15 P16050 5/20 0.53
LMNA P02545 4/20 0.53
USP2 O75604 3/20 0.53
TP53 P04637 2/20 0.53
CYP2C9 P11712 6/20 0.52
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
HIF1A Q16665 2/20 0.51
GLA P06280 2/20 0.51
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938450 0.85 CYP2D6 (0.62) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL940084 0.84 CYP2D6 (0.57) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1084218 0.84 CYP2D6 (0.60) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1084262 0.84 CYP2D6 (0.50) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1083829 0.83 CYP2D6 (0.70) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1083943 0.82 CYP2D6 (0.72) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL4512089 0.81 CHEK2 (0.42) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL4512084 0.81 CHEK2 (0.42) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL4512081 0.81 CHEK2 (0.42) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL2335352 0.80 CHEK2 (0.78) TSHRMAPK1SMN1; SMN2CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed